The effects of OC000459 on nasal Th2 cytokine release, eosinophil responses, and nasal symptoms after nasal allergen challenge (NAC) with timothy grass pollen in subjects with allergic rhinitis out of season
Phase of Trial: Phase I
Latest Information Update: 07 Oct 2006
At a glance
- Drugs OC 459 (Primary)
- Indications Allergic rhinitis
- Focus Biomarker; Pharmacodynamics
- 07 Oct 2006 New trial record.